Signe BioPharma Inc ®

Home

Core Values

Mission

Discovery

Business

History

Program Summary

Prevention

Products

Business Structure

Intellectual Property

Founders

Investor Information

What's New

Business Presentation

Business Plan

Plants

Bioreactors Today

Market Barriers

Markets

Capital Advantages

Conclusions

Plant Presentation

Dedication

Meet Signe

Signe Biography

Contact Us

Disclaimer

Market Barriers Today
  • Therapeutic antibodies cost $500 to $1000/gram
  • Multiple or successive treatments are very high cost - e.g. 3 milligrams per kilogram six times a year - 10,000 eighty kilogram patients will need 15 kilograms/year
  • Chronic disease treatment is too high cost
  • Health care focus - costs of goods - not benefits costs
  • Application of agricultural technology to the pharmaceutical industry is not commonplace today
  • Altering an existing production method requires a new FDA regulation approval - cost and time
  • Regulatory environment is evolving - early and frequent USDA and FDA regulation consultation is important

Home | Core Values | Mission | Discovery | History | Program Summary | Prevention | Products
Business Structure| Intellectual Property | Founders | Investor Information | What's New | Business Presentation
Business Plan | Bioreactors Today | Market Barriers | Markets
Capital Advantages | Conclusions | Plant Presentation | Meet Signe | Signe Biography | Contact Us | Disclaimer

© Copyright 2007 Signe BioPharma Inc. All Right Reserved.

Website powered by Network Solutions®